Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-03-30

FDA Approved: BUPRENORPHINE AND NALOXONE — Original Application (Rhodes Pharmaceuticals L.P.)

View source ↗

Summary

FDA approved the original application for a buprenorphine and naloxone combination product from Rhodes Pharmaceuticals L.P. for the treatment of opioid use diso…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Buprenorphine and naloxone (BUPRENORPHINE AND NALOXONE)

Snippet

ORIG AP for BUPRENORPHINE AND NALOXONE (BUPRENORPHINE AND NALOXONE)